Log on / register
Feedback | Support | My details
CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.
Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M
J Biol 2006, 5:22
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function.
Li Z, Dong T, Pröschel C, Noble M
PLoS Biol 2007 Feb, 5:e35
 [PubMed Central] [PubMed] [Related articles]
2.
The long term effects of chemotherapy on the central nervous system.
Duffner PK
J Biol 2006, 5:21
 [PubMed Central] [PubMed] [Related articles]
3.
Chemobrain: a translational challenge for neurotoxicology.
Weiss B
Neurotoxicology 2008 Sep, 29:891-8
 [PubMed Central] [PubMed] [Related articles]
4.
Tumor initiating cells in malignant gliomas: biology and implications for therapy.
Hadjipanayis CG, Van Meir EG
J Mol Med 2009 Apr, 87:363-74
 [PubMed Central] [PubMed] [Related articles]
5.
Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma.
Dietrich J, Wang D, Batchelor TT
Expert Opin Investig Drugs 2009 Oct, 18:1549-57
 [PubMed Central] [PubMed] [Related articles]
6.
Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation.
Abrajano JJ, Qureshi IA, Gokhan S, Zheng D, Bergman A, Mehler MF
PLoS One 2009, 4:e7665
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 3 articles in BioMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.